The General Pharmaceutical Council (GPhC) has called for comments and views on the recently launched consultation on selecting the appropriate mode of consultation when assessing a person’s needs by pharmacy professionals including pharmacist prescribers.
The guidance note sets out what the pharmacy professional or prescriber, in
agreement with the patient, needs to consider when selecting the mode of consultation - such as face-to-face; video-link, video-chat, or other online platforms; telephone and online questionnaires - best suited to gaining the information needed to deliver safe and effective pharmacy care.
The principles outlined in the guidance apply to consultations undertaken in all pharmacy settings, including those undertaken by online pharmacy services providers.
“Our plan is to include the contents of this guidance note in the document: ‘In practice: Guidance for pharmacist prescribers’ when we undertake our next review,” said the regulator.
“However, in the meantime we will be sharing this guidance note with all registrants once it has been finalized and will expect them to follow it when undertaking a consultation. We will be working to this guidance in our operational work, which includes inspections and fitness to practice (FtP).”
Any comments or questions about the guidance note, can be send to GPhC at: standards@pharmacyregulation.org by 30 June 2022.
Dymista® CONTROL (azelastine hydrochloride and fluticasone propionate) nasal spray ![Potential Side Effects of Mounjaro [What You Need to Know]](https://www.pharmacy.biz/media-library/image.jpg?id=54516976&width=1245&height=700&quality=90&coordinates=0%2C29%2C0%2C29)
